Rafferty Asset Management’s Myriad Genetics MYGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$600K Sell
112,948
-33,856
-23% -$180K ﹤0.01% 850
2025
Q1
$1.3M Sell
146,804
-19,334
-12% -$171K 0.01% 682
2024
Q4
$2.28M Buy
166,138
+55,690
+50% +$764K 0.01% 620
2024
Q3
$3.03M Buy
110,448
+16,992
+18% +$465K 0.01% 534
2024
Q2
$2.29M Sell
93,456
-155,747
-62% -$3.81M 0.01% 605
2024
Q1
$5.31M Buy
249,203
+77,804
+45% +$1.66M 0.02% 464
2023
Q4
$3.28M Sell
171,399
-37,085
-18% -$710K 0.01% 536
2023
Q3
$3.34M Buy
208,484
+12,232
+6% +$196K 0.02% 477
2023
Q2
$4.55M Buy
196,252
+26,411
+16% +$612K 0.03% 436
2023
Q1
$3.95M Sell
169,841
-36,492
-18% -$848K 0.03% 437
2022
Q4
$2.99M Buy
206,333
+35,049
+20% +$509K 0.03% 485
2022
Q3
$3.27M Buy
171,284
+62,482
+57% +$1.19M 0.03% 405
2022
Q2
$1.98M Sell
108,802
-22,185
-17% -$403K 0.02% 466
2022
Q1
$3.3M Sell
130,987
-45,935
-26% -$1.16M 0.02% 485
2021
Q4
$4.88M Buy
176,922
+83,152
+89% +$2.29M 0.03% 396
2021
Q3
$3.03M Buy
93,770
+6,032
+7% +$195K 0.02% 476
2021
Q2
$2.68M Sell
87,738
-19,614
-18% -$600K 0.02% 548
2021
Q1
$3.27M Buy
107,352
+86,871
+424% +$2.65M 0.02% 432
2020
Q4
$405K Sell
20,481
-60,067
-75% -$1.19M ﹤0.01% 733
2020
Q3
$1.05M Buy
80,548
+27,510
+52% +$359K 0.01% 573
2020
Q2
$601K Buy
53,038
+42,940
+425% +$487K 0.01% 667
2020
Q1
$145K Sell
10,098
-75,659
-88% -$1.09M 0.01% 544
2019
Q4
$2.34M Sell
85,757
-56,088
-40% -$1.53M 0.04% 334
2019
Q3
$4.06M Sell
141,845
-27,107
-16% -$776K 0.06% 180
2019
Q2
$4.69M Buy
168,952
+22,262
+15% +$618K 0.08% 178
2019
Q1
$4.87M Buy
+146,690
New +$4.87M 0.08% 142
2018
Q4
Sell
-17,518
Closed -$806K 687
2018
Q3
$806K Buy
+17,518
New +$806K 0.01% 493
2017
Q2
Sell
-126,205
Closed -$2.42M 581
2017
Q1
$2.42M Buy
+126,205
New +$2.42M 0.05% 184